SPACE study is a phase III trial evaluating AJOVY versus placebo over a 12-week period for the preventive treatment of episodic migraine in children and adolescents. According to the study ...
The timing of NICE’s review of the Aimovig verdict is unclear, and with Ajovy’s final guidance expected to be published next month Teva has an opportunity to access the NHS England market ...
The positive CHMP opinion is based on the review of a filing that included efficacy and safety data from the HALO clinical development programme. The programme evaluated Ajovy in two pivotal phase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback